Skip to Content

Atrovent HFA

In the US, Atrovent HFA (ipratropium systemic) is a member of the drug class anticholinergic bronchodilators and is used to treat Asthma and COPD - Maintenance.

US matches:

Ingredient matches for Atrovent HFA

Ipratropium

Ipratropium Bromide is reported as an ingredient of Atrovent HFA in the following countries:

  • Canada
  • Ecuador
  • United States

Ipratropium Bromide monohydrate (a derivative of Ipratropium Bromide) is reported as an ingredient of Atrovent HFA in the following countries:

  • Chile

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide